Pattern of Head and Neck Tumours in a North Central Nigerian Tertiary Hospital: An Epidemiological and Clinical Analysis

  • Home
  • Pattern of Head and Neck Tumours in a North Central Nigerian Tertiary Hospital: An Epidemiological and Clinical Analysis

Pattern of Head and Neck Tumours in a North Central Nigerian Tertiary Hospital: An Epidemiological and Clinical Analysis

1Enoch A Dahilo, 2Stephen S Yikawe, 3David F Folorunso, 4Kopdimma Botpoweh G
1,3,4Department of Otorhinolaryngology, university of Abuja/University of Abuja teaching hospital Gwagwalada Abuja
2Department of Otorhinolaryngology, head and neck surgery, Nigeria Air Force Hospital, Abuja.
 
ABSTRACT

Background: Head and neck tumours (HNTs) represent a significant global health burden, with marked geographical variations in incidence and histological patterns. While malignant lesions, particularly squamous cell carcinoma, have been widely studied, benign conditions such as adenotonsillar hypertrophy remain underreported despite their clinical relevance. This study aimed to characterise the epidemiological and clinicopathological profile of HNTs at the University of Abuja Teaching Hospital (UATH), Nigeria, and compare findings with regional and global trends.
Methods: A 10-year retrospective review (2013–2022) was conducted at the ENT Department of UATH. Data were extracted from patient records, including demographics, clinical presentation, histopathological diagnoses, risk factors, treatment modalities, and outcomes. Descriptive statistics were used to summarise categorical and continuous variables, while Chi-square tests assessed associations between variables. Statistical significance was set at p < 0.05.
Results: Of 337 patients analysed, 62.9% had benign lesions, while 6.2% were malignant. Males predominated (55.5%), and the mean age was 11.6 ± 16.7 years (47.2 ± 17.2 for malignant cases). Carcinomas (5.6%) were the most common malignancy, while adenotonsillectomy (66.8%) was the leading surgical intervention. Risk factor documentation was low (tobacco: 0.3%; alcohol: 2.1%). Notably, higher education levels correlated with malignancy (p = 0.0015). Late presentation was common, with 28.5% attributing delays to prior treatment at other clinics.
Conclusion: Benign HNTs were more prevalent than malignancies in this cohort. The predominance of late-stage presentations underscores systemic healthcare access challenges. The unexpected association between higher education and malignancy warrants further investigation. These findings highlight the need for enhanced diagnostic capacity, public awareness, and tailored interventions to improve HNT management in resource-limited settings.

 
KEYWORDS

Head and neck tumours, epidemiology, histopathology, Nigeria.

 
REFERENCES

1) Mody MD, Rocco JW, Yom SS, Haddad RI, Saba NF. Head and neck cancer. The Lancet [Internet]. 2021 Dec 18 [cited 2025 May 24];398(10318):2289–99. Available from: 

https://www.thelancet.com/action/showFullText?pii=S0140673621015506
2) Longo DL, Chow LQM. Head and Neck Cancer. Longo DL, editor. New England Journal of Medicine [Internet]. 2020 Jan 2 [cited 2025 May 24];382(1):60–72. Available from: 

https://www.nejm.org/doi/full/10.1056/NEJMra1715715
3) Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin [Internet]. 2018 Nov [cited 2025 May 24];68(6):394–424. Available from: 

https://pubmed.ncbi.nlm.nih.gov/30207593/

4) Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nature Reviews Disease Primers 2020 6:1 [Internet]. 2020 Nov 26 [cited 2025 May 24];6(1):1–22. Available from: 

https://www.nature.com/articles/s41572-020-00224-3
5) Altumbabić H, Salkić A, Ramaš A, Burgić M, Kasumović M, Brkić F. Pattern of head and neck malignant tumours in a Tuzla ENT clinic–a five-year experience. Bosn J Basic Med Sci [Internet]. 2008 [cited 2025 May 24];8(4):377–80. Available from: 

https://pubmed.ncbi.nlm.nih.gov/19125712/
6) Adoga AS, John EN, Yiltok SJ, Echejoh GO, Nwaorgu OGB. The pattern of head and neck malignant tumours in Jos. Highland Medical Research Journal. 2010 Mar 16;8(1).
7) Amutta S, Abdullahi M, Aliyu D, Manya C, Yikawe S, Solomon J. Pattern of otorhinolaryngeal, head and neck diseases in the inpatient unit of a tertiary health institution in Sokoto, North Western Nigeria. Borno Medical Journal [Internet]. 2015 [cited 2025 May 24];12(2):102–7. Available from:

https://www.ajol.info/index.php/bomj/article/view/255988

8) Adeyemi BF, Adekunle L V., Kolude BM, Akang EEU, Lawoyin JO. Head and Neck Cancer—A Clinicopathological Study in a Tertiary Care Center. J Natl Med Assoc. 2008 Jun 1;100(6):690–7.
9) Amusa YB, Olabanji JK, Ogundipe O V., Olateju SO, Agbakwuru EA, Ndukwe N, et al. Pattern of head and neck malignant tumours in a Nigerian teaching hospital–a ten year review. West Afr J Med [Internet]. 2004 Oct [cited 2025 May 24];23(4):280–5. Available from: https://pubmed.ncbi.nlm.nih.gov/15730084/
10) Rettig EM, D’Souza G. Epidemiology of head and neck cancer. Surg Oncol Clin N Am [Internet]. 2015 Jul 1 [cited 2025 May 24];24(3):379–96. Available from: 

https://pubmed.ncbi.nlm.nih.gov/25979389/
11) Franceschi S, Bidoli E, Herrero R, Muñoz N. Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol [Internet]. 2000 Jan [cited 2025 May 24];36(1):106–15. Available from: https://pubmed.ncbi.nlm.nih.gov/10889929/
12) Stordeur S, Schillemans V, Savoye I, Vanschoenbeek K, Leroy R, Macq G, et al. Comorbidity in head and neck cancer: Is it associated with therapeutic delay, post-treatment mortality and survival in a population-based study? Oral Oncol. 2020 Mar 1;102:104561.
13) Eytan DF, Blackford AL, Eisele DW, Fakhry C. Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States. Otolaryngol Head Neck Surg [Internet]. 2019 Jan 1 [cited 2025 May 24];160(1):85–92. Available from: 

https://pubmed.ncbi.nlm.nih.gov/30252608/
14) Aliyu A, Adelekan B, Andrew N, Ekong E, Dapiap S, Murtala-Ibrahim F, et al. Predictors of loss to follow-up in art experienced patients in Nigeria: A 13 year review (2004-2017). AIDS Res Ther [Internet]. 2019 Oct 8 [cited 2025 May 24];16(1):1–9. Available from: 

https://link.springer.com/articles/10.1186/s12981-019-0241-3
15) Bencina G, Chami N, Hughes R, Weston G, Golusiński PJ. Lost productivity due to head and neck cancer mortality in Hungary, Poland, and Romania. J Cancer Policy. 2022 Dec 1;34:100366.
16) Gilyoma JM, Rambau PF, Masalu N, Kayange NM, Chalya PL. Head and neck cancers: A clinico-pathological profile and management challenges in a resource-limited setting. BMC Res Notes [Internet]. 2015 Dec 12 [cited 2025 May 24];8(1):1–9. Available from: 

https://link.springer.com/articles/10.1186/s13104-015-1773-9
17) Iseh KR, Malami SA. Pattern of Head and Neck Cancer in Sokoto. Nigerian Journal of Otorhinolaryngology [Internet]. 2006 [cited 2025 May 24];3(2):77–83. Available from: 

https://www.ajol.info/index.php/njorl/article/view/32470


  • Share

Leave a Reply

Your email address will not be published. Required fields are marked *